Galenika has significantly expanded its presence in the pharmaceutical sector by securing an exclusive distribution agreement with Cantabria Labs, a leading Spanish dermatological brand.
This partnership allows Galenika to distribute Cantabria’s premium dermocosmetics in Serbia, Montenegro, and North Macedonia, enhancing its product offerings in these markets. With Cantabria Labs recognized for its high-quality standards and market-leading products in Europe, Galenika aims to bolster its competitive edge.
Amidst this strategic expansion, Galenika has also embarked on a robust investment cycle, focusing on modernizing production capabilities and environmental sustainability.
The company has invested €18.8 million since 2023 into new facilities and infrastructure improvements, including a significant overhaul of internal water systems to achieve a 10% reduction in water usage. These initiatives are part of Galenika’s broader strategy to enhance its international footprint and operational efficiency through continued digitalization and the upcoming implementation of ISO 27001 and Digital Manufacturing platforms.
Photo: Galenika
